David M. Stresser - Concepedia

Author

David M. Stresser

Also Known As

D M Stresser, D. M. Stresser, D.M. Stresser, DAVID M. STRESSER, David M. Stresser, David M Stresser, David M. Stresser, David Stresser, Stresser, David M.

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

BD Biosciences (United States)Oregon State University AbbVie (United States)AstraZeneca (United Kingdom)University of Massachusetts Chan Medical School

About

David M. Stresser is an author at BD Biosciences (United States) specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	770
2	Biochemistry	11	12	893
3	Natural Sciences	4	4	466
4	Health Sciences	1	1	31
5	Biomedical Engineering	1	1	75

David M. Stresser

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Substrate-Dependent Modulation of CYP3A4 Catalytic Activity: Analysis of 27 Test Compounds with Four Fluorometric Substrates David M. Stresser, Andrew P. Blanchard, Stephanie D. Turner, Drug Metabolism and Disposition	2000	273
Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity Gary L. Henderson, Martha R. Harkey, M. Eric Gershwin, Life Sciences C-dna-expressed Cytochrome P450BiochemistryNatural SciencesGinseng ComponentsMolecular Biology	1999	272
Cytochrome P450 Fluorometric Substrates: Identification of Isoform-Selective Probes for Rat CYP2D2 and Human CYP3A4. David M. Stresser, Stephanie D. Turner, Andrew P. Blanchard, Drug Metabolism and Disposition	2002	161
A High-Throughput Screen to Identify Inhibitors of Aromatase (CYP19) David M. Stresser, Stephanie D. Turner, Joanne McNamara, Analytical Biochemistry BiochemistryMedicineHigh-throughput ScreenAromataseMetabolomics	2000	136
HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE David M. Stresser, Marc I. Broudy, Thuy Ho, Drug Metabolism and Disposition	2004	128
Monospecific Antipeptide Antibody to Cytochrome P-450 2B6 David M. Stresser, David Kupfer Drug Metabolism and Disposition	1999	113
In Vitro Drug Metabolism Using Liver Microsomes David M. Stresser, John O. Miners Current Protocols in Pharmacology	2016	105
Fluorometric screening for metabolism-based drug–drug interactions Charles L. Crespi, David M. Stresser Journal of Pharmacological and Toxicological Methods Metabolism-based Drug–drug InteractionsDrug InteractionsDrug TargetBiochemistryMedicine	2000	100
Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat. David M. Stresser, G.S. Bailey, D E Williams Drug Metabolism and Disposition	1994	97
Fluorometric High‐Throughput Screening for Inhibitors of Cytochrome P450 Vaughn P. Miller, David M. Stresser, A. P. Blanchard, Annals of the New York Academy of Sciences Drug TargetPharmacotherapyPhysiologically-based Pharmacokinetic ModelingMolecular PharmacologyMedicinal Chemistry	2000	91

Page 1